Oncolytics Biotech Inc. (TSX:ONC)
Canada · Delayed Price · Currency is CAD 1.340
-0.060 (-4.29%)
Aug 14, 2025, 4:00 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.09M CAD
Market Cap
140.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Trulieve Cannabis | 6,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Extendicare | 23,000 |
Oncolytics Biotech News
- 3 days ago - Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - PRNewsWire
- 6 days ago - Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep - PRNewsWire
- 6 days ago - Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange - PRNewsWire
- 7 days ago - What to Expect from Oncolytics Biotech's Earnings - Benzinga
- 9 days ago - Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results - PRNewsWire
- 16 days ago - Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End - PRNewsWire
- 22 days ago - Key Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future Potential - PRNewsWire
- 23 days ago - Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules - PRNewsWire